The Global Blood Industry

  • ID: 4556078
  • Report
  • Region: Global
  • 293 pages
  • BCC Research
15 % OFF
until Jun 30th 2018
1 of 5

FEATURED COMPANIES

  • Abaxis Inc.
  • Beckman Coulter Inc.
  • Danaher Corp.
  • Hemocue Ab
  • Nova Biomedical Corp.
  • Revo Biologics
  • MORE
Report Scope:

This study encompasses the wide range of products and services that comprise the global blood-industry marketplace. The U.S. market, the largest in the world, provides the primary market breakdown with supplemental information given for other regions. The focus of the report is two-fold: first, blood for donation and the components and derived products from this blood and plasma, and second, products used to provide and support collection, processing and transfusion. Excluded from consideration are the clinical blood tests for diseases and conditions not involved in managing blood and plasma products.

Report Includes:
  • An overview of the structure and current market size of the global blood industry, including coverage of such segments as blood and plasma collection, blood and plasma processing, blood therapeutic products, plasma therapeutic products, and emerging trends and products
  • Analyses of global market trends, with data from 2013 to 2016, and projections of compound annual growth rates (CAGRs) through 2021
  • Analyses concerning blood therapeutics, processing, screening, and collection technologies
  • Evaluation of government and regulatory factors
  • The impact of diseases on the blood industry
  • An assessment of the market's dynamics, specifically growth drivers, restraints, and opportunities
  • Profiles of major players in the industry
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abaxis Inc.
  • Beckman Coulter Inc.
  • Danaher Corp.
  • Hemocue Ab
  • Nova Biomedical Corp.
  • Revo Biologics
  • MORE
Chapter 1 Introduction
Study Goals and Objectives
Reasons For Doing This Study
Contribution of the Study and Intended Audience
Scope and Format
Methodology and Information Sources
Analyst's Credentials
Related Reports

Chapter 2 Summary and Highlights
Overview
Major Findings
Major Trends
Key Findings

Chapter 3 Overview
The Blood Industry
Blood-Industry Terms and Abbreviations[1]
History of the Blood Industry
Blood and Its Components
Plasma
Cellular Elements
Immunoglobulin Products
The Dangers of Transfused Blood
Risks Associated With Transfusion
Efforts To Create a Virus-Free Blood Supply
Negative Reactions From Blood Transfusions
Blood/Plasma Component Risks
Albumins
Globulins
Fibrinogen
Plasma Constituents and Their Function
Red and White Blood Cells
Types of White Blood Cells
Platelets
National Healthcare Safety Network - Biovigilance Component Hemovigilance Module Surveillance
Diseases Contracted From Blood Transfusions and Related Identification Testing
Plasma Treatments
Platelet Treatments
Red Blood Cells
Granulocytes
Agranulocytes
Hiv/Aids
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatitis E
Human T-Cell Lymphotropic Virus
Cytomegalovirus
West Nile Virus
Mad Cow Disease - Creutzfeldt-Jakob Disease
Syphilis
Chagas Disease
Chlamydia Trachomatis
Neisseria Gonorrhoeae
Trinitrobutyl Phosphate and Sodium Cholate
Methylene-Blue-Treated Plasma
Amatosalen-Hcl-Treated Plasma
Advances In Rapid Syphilis Detection

Chapter 4 the Blood-Management System: Blood Collection, Processing and Use
Blood Collection
Blood Management Issues
Type of Blood Establishments and Blood Facilities
Organizations Collecting Blood
Blood-Donation Demographics
U.S. Demographics
European Demographics
Asia-Pacific Demographics
Donor Recruitment and Regulations
Blood-Donation Regulations: Amendments As of 2016
Blood Screening and Evaluation
Methods For Collecting Blood From a Donor
Plasma Collection
Blood Typing and Testing For Diseases
Blood Processing
Blood Transfusions
Types of Transfusions
Availability Issues
Bloodless Surgery
Safety Issues: Risk Management
Blood-Transfusion Fatalities
Major Facilities
Auxiliary Facilities
Transfusion Services
For-Profit Blood Collection
Plasma-Collection Centers
Nonprofit Blood Collection
Global Demographic Trends
Gender, Age and Life Expectancy
Global Life Expectancy
Manual Collection
Automated Collection
Commercial Nature of Plasmapheresis
Global Nature of the Plasma Industry
Key Stakeholders In the Plasma Market
Blood Typing
Methods of Typing
Blood Testing
Preparation and Use of the Components
Transfusion In the U.S.
Testing Before Transfusion
Whole Blood
Packed Red Blood Cells
Platelets
Leukocytes
Fresh Frozen Plasma
Cryoprecipitate
Coagulation Factors
Immune Serum Globulin/Imig/Ivig
Factor Viii
Factor Ix and Factor Ix Complex
Factor Viia
Fibrin/Thrombin
Therapeutic Apheresis
Experimental Blood and Plasma Products
Better Donor Screening
Better Viral Screening Tests
Get More Repeat Donors
Develop Better Viral Inactivation Processes
Selective Use of Blood-Derivative Products
National Donor Deferral Registry
American Red Cross
Community Blood Banks
Hospitals
Additional Blood-Collection Sites
Plasmapheresis
Plateletpheresis
Leukopheresis
Red Blood Cell Apheresis
Plasma Fractionators
Distributors/Brokers
Manual Blood-Typing Methods
Automated Blood-Typing and Blood-Screening Methods
Blood Storage
Red Blood Cell Components
Platelets
Plasma
Manual Cross-Match Techniques
Slide/Tile Testing
Tube Testing
Microplate
Major Cross-Match
Minor Cross-Match
Antibody Panel Screen
Coombs Test

Chapter 5 Regulation of the Blood Business
Regulation of the U.S. Blood Business
Statutory Authority of the Fda
The Major Regulations and Policy Matters Concerning the U.S. Blood Supply
How Regulations Are Implemented
Guidance For Industry Recognition and Use of a Standard For the Uniform Labeling of Blood and Blood Components
Other Organizations Involved In Blood Regulation
Voluntary Regulation by Professional and Trade Associations
The E.U. Blood Directive
Center For Biologics Evaluation and Research
Fda Guideline For Testing Zika Virus In Blood and Blood Components 2016
The Clinical Laboratory Improvement Act of 1988 (Clia)
Aabb Critical Appeal For Blood Supply In the U.S. 2016
The Fda's Five Layers
The Fda Blood Action Plan
Team Biologics
Inspecting Blood Banks and Plasma-Collection Facilities
National Heart, Lung and Blood Institute
Health Care Financing Administration
The Department of Defense
State Regulatory Agencies
Plasma Protein Therapeutics Association
America's Blood Centers
The International Society For Blood Transfusion - Isbt 128
Office of Regulatory Affairs
Office of Biologics, the Division of Blood and Blood Products
Donor Screening
Blood Testing
Donor-Deferral Lists
Quarantine
Problems and Deficiencies
Blood Diseases and Resources Program

Chapter 6 the Global Blood and Blood Products Market Overview
Driving Forces of the Industry
Market Summary
Demand For Plasma Derived Therapeutics
Pricing of Blood
Patterns of Transfusion Procedures
National Blood Exchange
Rbcs and Leukoreduced Rbcs
Platelets
Fresh Frozen Plasma
Cryoprecipitate
Washed Cells
Deglycerolized Cells
Granulocytes
Gamma-Irradiated Blood
Leukoreduction
Impact of Autologous Donations
Procedure Codes For Blood Transfusions and Related Services
Random-Donor Platelets
Types of Autologous Transfusions
Risks of Pabd

Chapter 7 Blood Industry Analysis
Global Markets For Whole Blood Collection
Global Markets For Source Plasma Collections
Global Markets For Blood Therapeutics
Global Markets For Blood Typing and Blood Screening Products
Screening Blood
Market Size of Blood Testing Products For Donor Screening
Blood Typing
Global Markets For Blood Processing Equipment and Associated Products
Local Efforts and Improvements
U.S. Blood Collection Data
Plasma and Plasma-Derived Products
Albumin and Plasma Protein Fraction
Clotting Factors
Immunoglobulins
Immunoglobulin Market Size
Fibrin Sealants and Thrombin
Antithrombin Iii
Polymerase Chain Reaction Amplification
Nucleic Acid Amplification Test
Immunoassay
Market Structure and Participants
Market Size of Blood Typing
Collection Products
Blood and Plasma Collection Supplies
Blood and Plasma Collection Equipment
Market Participants
Transfusion Products
Africa
Asia
Europe
North America and the Caribbean
Oceania and Southeast Asia
South America
Recombinant Human Albumin
Albumin Market Dynamics
Albumin and Ppf Market Size
Albumin and Ppf Market Trends
Hemophilia
Market Demand and Market Size
Factor Viii
Factor Ix
Factor Viia
Biosimilar Factor Viia Development
Factor Xiii
Prothrombin Complex Concentrates
Polyvalent Immunoglobulins
Hyperimmune Immunoglobulins
Ivig
Hyperimmune Immunoglobulins
Other
Respiratory Syncytial Virus
Hepatitis B Immune Globulin
Alpha-1 Proteinase Inhibitor
Other Immunoglobulin Segments
Cryoseal
Tisseel
Fibrin Sealants and Thrombin Market Size
Antithrombin Market Size
Manual Typing Methods
Automated Blood Typing
Plasma Collection Sets
Blood Bags
Blood Salvage
Other Collection Equipment
Haemonetics
Fresenius Kabi (Fenwal Inc.)
Terumo Bct
Transfusion Sets
Blood Filter Market
Transfusion Equipment
Accessories
South Africa
China
India
Japan
Pakistan
Iran
Sri Lanka
Vietnam
U.K.
France
Germany
Russia
Montenegro
The Netherlands
Switzerland
Turkey
Canada
Haiti
Australia
New Zealand
Cook Islands
Argentina
Bolivia
Brazil
Plasma Therapeutic Products
Imig
Cytomegalovirus Immunoglobulin
Rabies Immunoglobulin
Rho(D) Immunoglobulin
Tetanus Immunoglobulin
Vaccinia Immune Globulin Intravenous
Varicella Immunoglobulin
Beckman Coulter
Immucor
Ortho Clinical Diagnostics
Pcs2
Cymbal
Mcs+ 8150 System
Mcs+ 9000 System
Cell Saver Systems
Orthopat System
Acp 215 System
Autopheresis-C
Alyx Component Collection System
Amicus Separator
Aurora

Chapter 8 Blood Research and Development
Dedicated Blood Research Facilities
Stem Cell Research
Blood Substitutes
Recombinant Development Activities
New Developments In Immunoglobulins
The Veterinary Blood Market
Jerome H. Holland Laboratory (American Red Cross)
National Blood Foundation
Csl Behring's Commitment To Clotting-Factor Development
Baxter Rixubis Clotting-Factor Development
Fibrin Sealant and Glue Developments
Albumin and Intravenous Immunoglobulin Treatment For Alzheimer’S Disease
Investigational Device To Help Improve Blood-Supply Safety

Chapter 9 Technology
Classic Fractionation Methods
Advanced Fractionation Methods
Amplification Methods
Immunoassay
Patent Analysis
Patent Examples
Cohn Fractionation
Microfluidic Fractionation
Polymerase Chain Reaction
Nucleic Acid Amplification Technology
Enzyme Immunoassay
Recent Patents
Basic Eia
Alternate Eia Methods
Blood Transfusions: Eight Patents
Blood Bank: Three Patents
Blood Donor: Three Patents
Second-Antibody Precipitation Method
Monoclonal-Polyclonal Sandwich Immunoassay
Double-Antibody Sandwich Method
Reverse-Sandwich Method
Competitive-Inhibition Immunoassay
Rapid Immunoassay

Chapter 10 Fda-Licensed Blood Establishments
Guidance For Industry Recognition and Use of a Standard For the Uniform Labeling of Blood and Blood Components
Labeling Standards
Reporting Requirements For Licensed Establishments
Fda-Licensed Establishments

Chapter 11 Company Profiles
Abbott Laboratories
Astrazeneca Plc
Baxter International Inc.
Bayer Ag
Bio-Rad Laboratories Inc.
Csl Behring
Entegrion Inc.
Grifols International S.A./Talecris
Haemonetics Corp.
Hologic Inc.
Lfb Group
Novo Nordisk A/S
Octapharma Ag
Pfizer Inc.
Roche Holding Ltd.
Sanofi S/A

Chapter 12 Major Sources of Information
Companies
Abaxis Inc.
Abbott Laboratories
Albumin Bioscience
Alere Inc.
Alfa Scientific Designs Inc.
American Red Cross
Arkray Inc.
Aryogen Biopharma Co.
Astrazeneca Plc
Avioq Inc.
Baxter International Inc.
Bayer Ag
Beckman Coulter Inc.
Becton, Dickinson, & Co.
Biogen Idec
Biomerieux France
Bio Products Laboratory Ltd.
Bio-Rad Laboratories Inc.
Biotest Ag
Bristol-Myers Squibb Co.
Btg International
Btnx Inc.
Cangene Corp. (See Emergent Biosolutions)
Charter Medical Ltd.
Church & Dwight Co. Inc.
Csl Behring
Danaher Corp.
Emergent Biosolutions
Entegrion Inc.
Fora Care Inc.
Fresenius Kabi Ag
Fujirebio Diagnostics Inc.
Gambro Inc.
G.E. Healthcare Ltd.
Glaxosmithkline Plc
Grifols International, S.A.
Haemonetics Corp.
Haemotronic S.P.A.
Hemacare Corp.
Hemocue Ab
Hologic Inc.
Immucor Inc.
International Technidyne Corp.
Jant Pharmacal Corp.
Johnson & Johnson
Kedrion S.P.A
Lfb Group
Meridian Bioscience Inc.
National Genetics Institute
Nextron Medical Technologies
Nipro Diagnostics Inc.
Nova Biomedical Corp.
Novartis Ag
Novo Nordisk A/S
Novozymes Biopharma Dk A/S
Octapharma Ag
Omrix Biopharmaceuticals Ltd. (See Johnson & Johnson)
Orasure Technologies Inc.
Ortho Clinical Diagnostics Inc.
Pall Corp.
Pfizer Inc.
Phamatech Inc.
Princeton Biomeditech Corp.
Qiagen N.V.
Quest Diagnostics
Quidel Corp.
Response Biomedical Corp.
Revo Biologics
Roche Holding Ltd.
Sanofi S/A
Sanquin Blood Supply
Sa Scientific Ltd.
Sekisui Diagnostics
Siemens Medical Solutions
Spectral Diagnostics
Stanbio Laboratory
Takeda Pharmaceutical Co. Ltd.
Terumo Bct
Trinity Biotech Plc
Zeus Scientific Inc.
Global Blood Donation Sources
American Association of Blood Banks
American Friends of Magen David Adom
Armed Services Blood Program
Association of Voluntary Italian Blood Donors
Australian Red Cross
Canadian Blood Services
Heartland Blood Centers
Hong Kong Red Cross
Indian Red Cross Society
Irish National Blood Centre
Japanese Red Cross Society
National Blood Service
New Zealand Blood Service
South African National Blood Service
World Health Organization
Program Alignment Action Plan For Fiscal 2015
Fuel, Phone Excise Taxes

List of Tables
Summary
Table 1: Summary Table: Global Sales of Blood Products, Through 2021
Table 2: Timeline of the Blood Industry
Table 3: Composition of Blood
Table 4: Plasma Constituents and Their Function
Table 5: U.S. Analysis of Major Diseases Contracted From Blood Transfusions
Table 6: Cber-Licensed Screening Tests For Hiv
Table 7: Cber-Licensed Screening Tests For Hepatitis B
Table 8: Cber-Licensed Screening Tests For Hepatitis C
Table 9: Cber-Licensed Screening Tests For Htlv-I and Hylv-Ii
Table 10: Cber-Licensed Screening Tests For Cmv
Table 11: Cber-Licensed Screening Tests For West Nile Virus
Table 12: Cber-Approved Manufacturers For Syphilis Tests
Table 13: Cber-Licensed Screening Tests For Trypanosoma Cruzi
Table 14: Cber-Approved Manufacturers For Chlamydia Screening Tests
Table 15: Cber-Licensed Screening Tests For Gonorrhea
Table 16: Blood Establishments and Blood Facilities
Table 17: Fda-Registered Blood Establishments by U.S. State* and Possession
Table 18: Global Abo and Rh Blood Type Distribution Across Countries, 2015
Table 19: Global Population Annual Growth by Selected Age Group and Years, Through 2030
Table 20: Global Population by Selected Country, 2015 and 2020
Table 21: U.S. Population by Age Group, 2020-2050
Table 22: Expected U.S. Life Expectancy At Birth With Projections, by Gender, 2015 and 2020
Table 23: European Population, by Age Group, 2016-2050
Table 24: Asia-Pacific Population, by Age Group, 2016-2050
Table 25: Global Life Expectancy, 2010-2015
Table 26: Global Life Expectancy At Birth, by Selected Country, 2013 and 2014
Table 27: Diseases That Can Be Treated With Plasmapherisis
Table 28: Red Blood Cells Compatibility
Table 29: Red Blood Cells Compatibility
Table 30: Fda Approved Plasma Providers
Table 31: Distribution of Blood Types In the U.S.
Table 32: Tests Routinely Performed On Blood Donations
Table 33: Blood Type Antigen-Antibody Reactions
Table 34: Processing of Donated Blood
Table 35: Compatibility of Abo and Rh System
Table 36: Selected Uses of Fresh Frozen Plasma
Table 37: Usage and Therapeutic Effect
Table 38: Listing of Blood Products For Therapeutic Use
Table 39: Bloodless Medicine and Surgery Hospital Directory
Table 40: Factors To Reduce Risks of Transfusion-Associated Diseases
Table 41: Transfusion-Related Fatalities by Complication, Fy2008-Fy2013
Table 42: Fatalities Not Related To Transfusion Or Transfusion Not Ruled Out, Fy2008-Fy2013
Table 43: Postdonation “Not Ruled Out” Fatality Reports by Donated Product, Fy2008-Fy2013
Table 44: Federal Organizations Responsible For U.S. Blood Safety
Table 45: Fda Authority In Regulating Blood Banking and Blood Products
Table 46: Major Areas of Concern For Inspecting Blood Facilities
Table 47: U.S. Cost of Blood Components, Through 2014
Table 48: U.S. Blood Transfusion and Related Services Codes
Table 49: Extent of Specific Legislation Covering Safety and Quality of Blood Transfusion
Table 50: Blood Use In India
Table 51: Donation and Distribution (Jrcs 2015)
Table 52: Consumption of Blood Products In Transfusions In Germany, 2015
Table 53: U.S. Blood Collection and Transfusion Data, Through 2021*
Table 54: Global Plasma Collection and Values, Through 2021
Table 55: Global Sales of Plasma Therapeutics, *Through 2021
Table 56: Global Market For Plasma Therapeutic Derivatives, by Type, Through 2021
Table 57: Albumin and Ppf Products
Table 58: Global Market For Albumin and Ppf, Through 2021
Table 59: Global Market For Albumin and Ppf, by Country, Through 2021
Table 60: Examples of Blood Clotting Factors
Table 61: Global and U.S. Hemophilia Statistics*
Table 62: Global Market For Plasma-Derived and Recombinant Clotting Factors, Through 2021
Table 63: Global Market For Plasma-Derived and Recombinant Clotting Factors by Country, Through 2021
Table 64: Base Cost and Range of Some Known Factor Viii Products
Table 65: Approved Factor Viii Products
Table 66: Global Market Shares of Factor Viii Companies, 2016
Table 67: Average Cost and Price Range of Commonly Used Factor Ix Concentrates
Table 68: Approved Factor Ix Products
Table 69: Global Market Shares of Factor Ix Companies, 2016
Table 70: Approved Factor Vii Products (Recombinant: Human)
Table 71: Global Market Shares of Factor Vii Companies, 2016
Table 72: Approved Factor Xiii Products (Source: Recombinant)
Table 73: Approved Prothrombin Complex Concentrate Products From Human Plasma
Table 74: Selected Conditions Treated by Ivig
Table 75: Approved Immunoglobulins
Table 76: Approved Hyperimmune Immunoglobulins
Table 77: Global Market For Immunoglobulins, Through 2021
Table 78: Global Market For Immunoglobulins, by Country, Through 2021
Table 79: Global Market Shares of Immunoglobulin Companies, 2016
Table 80: Approved Fibrin Sealants and Fibrin Products
Table 81: Global Market For Fibrin Sealants and Thrombin, Through 2021
Table 82: Global Market For Fibrin Sealants and Thrombin, by Country, Through 2021
Table 83: Global Market Shares of Fibrin Sealants and Thrombin Product Companies, 2016
Table 84: Approved Antithrombin Products
Table 85: Global Market For Antithrombin, Through 2021
Table 86: Global Market For Antithrombin, by Country, Through 2021
Table 87: Global Market For Blood Typing and Blood Screening Products, by Country, Through 2021
Table 88: Global Market For Blood Typing and Blood Screening Products, Through 2021
Table 89: Selected Pcr Donor Screening Tests
Table 90: Selected Nat Donor Screening Tests
Table 91: Selected Immunoassay Donor Screening Tests
Table 92: Global Blood Donor Screening Testing Market, by Type of Test, Through 2021
Table 93: Blood Group and Rh Type and Compatible Blood For Transfusion
Table 94: Global Instruments and Supplies Market For Blood Typing, by Type, Through 2021
Table 95: Global Market For Blood Collection and Blood Processing Equipment and Disposables, by Country, Through 2021
Table 96: Global Market For Blood and Plasma Collection/Transfusion Products, Through 2021
Table 97: Global Market For Blood Collection Products, by Type, Through 2021
Table 98: Global Market For Transfusion Products, by Type, Through 2021
Table 99: Nbf Fundraising Results, 2015
Table 100: Top Fibrin Sealant and Glue Products and Their Development
Table 101: Clinical Trial: Albumin In Alzheimer's Treatment
Table 102: Dog and Cat Blood Types and Descriptions
Table 103: U.S. and Canada Regional Veterinary Blood Banks
Table 104: Application of Nat Other Than Detection
Table 105: Abott's Sales History, 2013-2015
Table 106: Astrazeneca's Sales History, 2013-2015
Table 107: Baxter's Sales History, 2013-2015
Table 108: Bayer's Sales History, 2013-2015
Table 109: Bio-Rad's Sales History, 2013-2015
Table 110: Csl Limited's Sales History, 2013-2015
Table 111: Grifol's Sales History, 2013-2015
Table 112: Haemonetics' Sales History, 2013-2015
Table 113: Hologic's Sales History, 2013-2015
Table 114: Lfb Group's Sales History, 2013-2015
Table 115: Novo Nordisk's Sales History, 2013-2015
Table 116: Octapharma's Sales History, 2013-2015
Table 117: Pfizer's Sales History, 2013-2015
Table 118: Roche's Sales History, 2013-2015
Table 119: Sanofi's Sales History, 2013-2015

List of Figures
Figure 1: Summary Figure: Global Sales of Blood Products, 2013-2021
Figure 2: U.S. Total Plasma Collection, 2010-2015
Figure 3: Global Population Annual Growth by Selected Age Group and Years, 2010-2030
Figure 4: U.S. Population by Age Group, 2020-2050
Figure 5: U.S. Life Expectancy At Birth by Gender, 2015 and 2020
Figure 6: European Population, by Age Group, 2016-2050
Figure 7: Asia-Pacific Population, by Age Group, 2016-2050
Figure 8: Global Life Expectancy At Birth, by Selected Country, 2013 and 2014
Figure 9: Plasma Products’ Demand, 2010-2016
Figure 10: Global Demand For Factor Viii, 2010-2016
Figure 11: Variables Influencing the Dynamics of Demand For Blood For Transfusion
Figure 12: Blood Market Cost and Pricing Analysis
Figure 13: Increasing Geriatric Population Base In Africa (60 Years and Older), 2000-2050
Figure 14: Increasing Geriatric Population Base In Africa (60 Years and Older), 2000-2050
Figure 15: Number of Organs Transplanted In China, 2010-2015
Figure 16: Percent of Voluntary Blood Donors In Naco-Supported Blood Banks, 2006-2016
Figure 17: Increasing Geriatric Population (60 Years and Older) In Europe, 2000-2050
Figure 18: U.S. Blood Collection and Transfusion Data, 2014-2021
Figure 19: Global Market For Plasma Collections, 2015-2021
Figure 20: Global Market For Plasma Therapeutics, *2013-2021
Figure 21: Global Market Shares of Plasma Therapeutic Sales, by Country, 2015
Figure 22: Global Market For Plasma Therapeutic Derivatives by Type, 2013-2021
Figure 23: Global Market For Albumin and Ppf, 2013-2021
Figure 24: Global Market For Albumin and Ppf by Country, 2013-2021
Figure 25: Global Market For Plasma-Derived and Recombinant Clotting Factors, 2013-2021
Figure 26: Global Market Shares of Clotting Factor Sales, by Human and Recombinant Products, 2015
Figure 27: Global Market For Plasma-Derived and Recombinant Clotting Factors by Country, 2013-2021
Figure 28: Global Market Shares of Factor Viii Companies, 2016
Figure 29: Global Market Shares of Factor Viii Sales, by Human and Recombinant Products, 2015
Figure 30: Global Market Shares of Factor Ix Companies, 2016
Figure 31: Global Market Shares of Factor Ix Sales, by Human and Recombinant Products, 2015
Figure 32: Global Market Shares of Factor Vii Companies, 2016
Figure 33: Global Market For Immunoglobulins, 2013-2021
Figure 34: Global Market For Immunoglobulins, by Country, 2013-2021
Figure 35: Global Market Shares of Immunoglobulin Companies, 2016
Figure 36: Global Market For Fibrin Sealants and Thrombin, 2013-2021
Figure 37: Global Market For Fibrin Sealants and Thrombin by Country, 2013-2021
Figure 38: Global Market Shares of Fibrin Sealants and Thrombin Product Companies, 2016
Figure 39: Global Market For Antithrombin, 2013-2021
Figure 40: Global Market For Antithrombin, by Country, 2013-2021
Figure 41: Global Market For Blood Typing and Blood Screening Products, by Country, 2013-2021
Figure 42: Global Market Shares of Blood Typing and Blood Screening Product Sales, by Country, 2015
Figure 43: Global Market For Blood Typing and Blood Screening Products, 2013-2021
Figure 44: Global Blood Donor Screening Testing Market, by Type of Test, 2013-2021
Figure 45: Global Instruments and Supplies Market For Blood Typing, by Type, 2013-2021
Figure 46: Global Market For Blood Collection and Blood Processing Equipment and Disposables, by Country, 2013-2021
Figure 47: Global Market Shares of Blood Collection and Blood Processing Equipment and Disposables, by Country, 2015
Figure 48: Global Market For Blood and Plasma Collection/Transfusion Products, 2013-2021
Figure 49: Global Market For Collection Products, by Type, 2013-2021
Figure 50: Global Market For Transfusion Products, by Type, 2013-2021
Figure 51: Application Research Content Area Distribution, 2015
Figure 52: Nih Spending On Stem Cell Research, 2013-2016
Figure 53: Recombinant Development Activities' Current Scenario of New Drugs, 2015
Figure 54: the Basic Enzyme Immunoassay Process
Figure 55: Abott’S Sales History, 2013-2015
Figure 56: Astrazeneca's Sales History, 2013-2015
Figure 57: Baxter's Sales History, 2013-2015
Figure 58: Bayer's Sales History, 2013-2015
Figure 59: Bio-Rad's Sales History, 2013-2015
Figure 60: Csl Limited's Sales History, 2013-2015
Figure 61: Grifol's Sales History, 2013-2015
Figure 62: Haemonetics' Sales History, 2013-2015
Figure 63: Hologic's Sales History, 2013-2015
Figure 64: Lfb Group's Sales History, 2013-2015
Figure 65: Novo Nordisk's Sales History, 2013-2015
Figure 66: Octapharma's Sales History, 2013-2015
Figure 67: Pfizer's Sales History, 2013-2015
Figure 68: Roche's Sales History, 2013-2015
Figure 69: Sanofi's Sales History, 2013-2015
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abaxis Inc.
  • Abbott Laboratories
  • Albumin Bioscience
  • Alere Inc.
  • Alfa Scientific Designs Inc.
  • American Association of Blood Banks
  • American Friends of Magen David Adom
  • American Red Cross
  • Arkray Inc.
  • Armed Services Blood Program
  • Aryogen Biopharma Co.
  • Association of Voluntary Italian Blood Donors
  • Astrazeneca Plc
  • Australian Red Cross
  • Avioq Inc.
  • Baxter International Inc.
  • Bayer AG
  • Beckman Coulter Inc.
  • Becton, Dickinson, & Co.
  • Bio Products Laboratory Ltd.
  • Bio-Rad Laboratories Inc.
  • Biogen Idec
  • Biomerieux France
  • Biotest AG
  • BTG International
  • BTNX Inc.
  • Canadian Blood Services
  • Cangene Corp. (See Emergent Biosolutions)
  • Charter Medical Ltd.
  • Church & Dwight Co. Inc.
  • CSL Behring
  • Danaher Corp.
  • Emergent Biosolutions
  • Entegrion Inc.
  • Fora Care Inc.
  • Fresenius Kabi AG
  • Fujirebio Diagnostics Inc.
  • G.E. Healthcare Ltd.
  • Gambro Inc.
  • Glaxosmithkline Plc
  • Grifols International S.A./Talecris
  • Grifols International, S.A.
  • Haemonetics Corp.
  • Haemotronic S.P.A.
  • Heartland Blood Centers
  • Hemacare Corp.
  • Hemocue Ab
  • Hologic Inc.
  • Hong Kong Red Cross
  • Immucor Inc.
  • Indian Red Cross Society
  • International Technidyne Corp.
  • Irish National Blood Centre
  • Jant Pharmacal Corp.
  • Japanese Red Cross Society
  • Kedrion S.P.A
  • LFB Group
  • Meridian Bioscience Inc.
  • National Blood Service
  • National Genetics Institute
  • New Zealand Blood Service
  • Nextron Medical Technologies
  • Nipro Diagnostics Inc.
  • Nova Biomedical Corp.
  • Novartis AG
  • Novo Nordisk A/S
  • Novozymes Biopharma Dk A/S
  • Octapharma AG
  • Omrix Biopharmaceuticals Ltd. (See Johnson & Johnson)
  • Orasure Technologies Inc.
  • Ortho Clinical Diagnostics Inc.
  • Pall Corp.
  • Pfizer Inc.
  • Phamatech Inc.
  • Princeton Biomeditech Corp.
  • Qiagen N.V.
  • Quest Diagnostics
  • Quidel Corp.
  • Response Biomedical Corp.
  • Revo Biologics
  • Roche Holding Ltd.
  • SA Scientific Ltd.
  • Sanofi S/A
  • Sanquin Blood Supply
  • Sekisui Diagnostics
  • Siemens Medical Solutions
  • South African National Blood Service
  • Spectral Diagnostics
  • Stanbio Laboratory
  • Takeda Pharmaceutical Co. Ltd.
  • Terumo Bct
  • Trinity Biotech Plc
  • World Health Organization
  • Zeus Scientific Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll